Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic.

ABSTRACT:

Objective

Patients with rheumatic diseases such as rheumatoid arthritis (RA) and lupus have increased risk of infection and are treated with medications that may increase this risk yet are also hypothesized to help treat COVID-19. We set out to understand how the COVID-19 pandemic has impacted the lives of these patients in the United States.

Methods

Participants in a US-wide longitudinal observational registry responded to a supplemental COVID-19 questionnaire by e-mail on March 25, 2020, about their symptoms, COVID-19 testing, health care changes, and related experiences during the prior 2 weeks. Analysis compared responses by diagnosis, disease activity, and new onset of symptoms. Qualitative analysis was conducted on optional free-text comment fields.

Results

Of t

SUBMITTER: Michaud K 

PROVIDER: S-EPMC7264613 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature